287 results on '"De Gobbi, Marco"'
Search Results
2. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
3. Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
4. Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
5. GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
6. Annotation of Cis-Regulatory Elements by Identification, Subclassification, and Functional Assessment of Multispecies Conserved Sequences
7. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease
8. P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIAN, MULTI-RESISTANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENT POPULATION
9. P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
10. Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy
11. Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase.
12. Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis
13. A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter
14. Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)
15. High-resolution analysis of cis-acting regulatory networks at the α-globin locus
16. Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes
17. Intragenic Enhancers Act as Alternative Promoters
18. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
19. Adventitious Changes in Long-Range Gene Expression Caused by Polymorphic Structural Variation and Promoter Competition
20. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1α localization in erythroblasts
21. HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
22. ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner
23. Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study
24. A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion
25. Development of cellular and humoral response against WT1 protein vaccination in mice
26. An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment
27. The role of the polycomb complex in silencing α-globin gene expression in nonerythroid cells
28. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
29. Tissue-specific histone modification and transcription factor binding in α globin gene expression
30. Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1
31. Analysis of Sequence Variation Underlying Tissue-specific Transcription Factor Binding and Gene Expression
32. Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells
33. Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
34. HSCT With Mismatch Unrelated Donor: A Comparison of ATG vs. PT-Cy-Based GvHD Prophylaxis in Pediatric and Adult Patients
35. Natural history of juvenile haemochromatosis
36. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
37. TFR2 Y250X mutation in Italy
38. TFR2-Related Hereditary Hemochromatosis
39. Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study
40. Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease
41. Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature
42. Transferrin Saturation Inversely Correlates with Platelet Function
43. Generation of bivalent chromatin domains during cell fate decisions
44. Juvenile hemochromatosis
45. Genetic haemochromatosis: genes and mutations associated with iron loading
46. Hemochromatosis Due to Mutations in Transferrin Receptor 2
47. Enhancer deletion generates cellular phenotypic diversity due to bimodal gene expression
48. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
49. ERYTHROFERRONE EXPRESSION LEVELS IN MYELODYSPLATIC SYNDROMES SHOW CLINICAL RELEVANCE
50. Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.